So what are the barriers preventing or delaying adoption?
TORONTO (PRWEB) September 30, 2020
Automation, and its big brother AI, have been hot topics in Pharmacovigilance for several years now, linked to the technology’s promise to transform all kinds of high-volume manual processes. So why isn’t there universal adoption within the industry?
In the experience of this webinar’s presenter Dr. John Price, a consultant to life sciences organizations around the world, there has been remarkably sparse uptake of next-generation tech solutions for case intake, given their scope for process transformation.
So what are the barriers preventing or delaying adoption? As an advisory Board member to consulting services provider Arriello - which promotes and uses an automated case-intake solution to expedite and enhance the quality and completeness of adverse event reporting - Dr. Price has a rounded interest in discovering more about what is going on. This curiosity prompted a US/UK survey of 200 PV professionals, commissioned by Arriello and conducted in June 2020, investigating attitudes towards case intake automation and adjacent PV activities.
Join Dr. John Price, MB ChB, PhD, BSc, Pharmacovigilance Consultant, Arriello Advisory Board member in a live webinar on Thursday, October 15, 2020 at 11am EDT (4pm BST/UK).
For more information or to register for this event, visit Case Intake: Making Next-Gen into “Now Gen.”
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.